A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiency

Shanghai Municipal Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) those who meet the diagnostic criteria of coronary heart disease, chronic heart failure and Yang deficiency and Blood Stasis Syndrome of TCM;
•(2) those aged 18 to 75;
•(3) those who have not taken any other proprietary Chinese medicine or decoction for treating coronary heart disease with heart failure within 2 weeks;
•(4) the patient informed and consented to the study and has signed the informed consent form, in line with our hospital ethics committee certification, all treatment and examination are informed consent of patients or family members.

•(1) with Cardiogenic shock, severe ventricular Arrhythmia, complete atrioventricular block, obstructive cardiomyopathy, severe valvular heart disease, severe pericardial disease;
•(2) allergic to or allergic to multiple drugs;
•(3) suffering from serious diseases such as liver, kidney, brain, blood system and infection;
•(4) non-cooperative patient or patient with mental disease;
•(5) hypertension, diabetes not under control or unstable control;
•(6) inability to work with researchers due to disability or mental illness.

发起方